Seller review · costs and terms
RoenRx review
RoenRx displays semaglutide at $151 per month when purchased quarterly. Its insurance-dependent brand headline and membership policy leave a flexible one-month cash total unresolved.
By Jenna Pratt, consumer-access reporter · Updated October 2026
Itemized bill
RoenRx
Totals are our arithmetic from the seller’s published figures. Extra fees unconfirmed: the seller states no amount for plan membership or clinical assessment or recommended diagnostic tests. Confirm these charges and the medication price before paying.
The bill, in one line
Request a prescription-specific order summary covering the quarterly charge, renewal and included clinical access. The headline alone does not establish an amount that can be paid for just one month.
Roen Health, Inc. is the operator named in RoenRx’s current terms. The technology business is separate from the clinical service. Its weight offering includes insurance assistance for brands and access to compounded prescriptions through independent clinicians. In June 2026, FDA issued a letter about website material reviewed that March. Label images suggested RoenRx itself compounded the preparations. The agency also challenged ingredient comparisons implying FDA evaluation or approval. Those historical representations require context, but do not settle a prescription’s current cost. No FDA closeout was confirmed.
RoenRx’s $151 semaglutide advertisement explicitly requires quarterly purchase. Treat it as a qualified equivalent, rather than an available one-month checkout amount. Insurance also controls the separate $25 branded figure; it is not a price that buyers without insurance can count on. The contract distinguishes an access membership from prescription-inclusive programs. General access does not inherently pay for medication or fulfillment. Named semaglutide-plus-doctor and tirzepatide-plus-doctor programs include those items. Request an itemized quote showing the selected program’s full charge, remaining exclusions and renewal dates. The public card alone leaves those details unsettled.
Fees outside the headline
Plan membershipnot published
Membership required for selected access; no universal amount verified, specific medication-inclusive programs distinguished.
Read October 2026
Clinical assessmentnot published
Homepage promises free consultations but policy describes nonrefundable provider or consultation fees; selected plan needs confirmation.
Read October 2026
Pharmacy shippingincluded
Homepage explicitly advertises free shipping; confirm chosen program exclusions under general charge terms.
Read October 2026
Recommended diagnostic testsnot published
Policy permits diagnostic testing charges but no universal price or included allowance established.
Read October 2026
See RoenRx’s current price
Check the seller’s own page before you pay.
The fine print
- Prepay
- Automatic membership renewals continue unless canceled. Some weight prescriptions require several months of membership to support the supplied medication. The quarterly card does not disclose the precise collection timetable. Obtain the due-now payment, later obligations and renewal frequency together. A term expressed as a monthly equivalent does not make each month independently purchasable.
- Cancellation
- Cancellation starts in the account through Manage Membership and Manage Your Plan before renewal. An unused portion of the current membership period ordinarily receives no prorated refund. Consultation and provider-visit charges are also described as nonrefundable. The policy denies ordinary prescription returns after the prescription is issued and filled by the pharmacy. A later passage refers to orders being final after shipment. Ask which pharmacy-processing event closes cancellation before payment, rather than assuming there is a dispatch grace period.
- Shipping
- The homepage advertises free pharmacy shipping. The payment policy separately reserves possible delivery and testing charges, so confirm the selected program’s exclusions. Ask who ships the prescription, what happens after a lost package and whether a replacement creates another charge.
FDA warning letters
- Letter 728293: FDA primary letter
Worth it, and what to watch
Worth it
- Quarterly qualification visible
- Self-service cancellation described
- Medication-inclusive programs distinguished
Watch for
- No flexible monthly cash quote
- Membership amount requires confirmation
- Prescription refunds restricted
- Buy here if
- A buyer willing to obtain the complete quarterly charge and renewal agreement before comparing costs.
- Look elsewhere if
- Someone treating an insured copay or quarterly equivalent as a universal one-month cash total.
FAQ
3 questionsCan $151 be paid for just one month?
The card qualifies that amount with a quarterly purchase. A flexible one-month option at the same amount was not established.
Are medication costs always part of membership?
No. The policy distinguishes general access membership from named medication-plus-doctor programs. Obtain the selected program’s written inclusions.
Does the FDA letter concern the current bill?
The June 2026 letter concerns historical marketing and pictured labels, not a finding that the public price is incorrect. No closeout was confirmed.
Price it at RoenRx
Every figure above was read from RoenRx’s own pages. The current one is a click away.
Questions the research answers
Other sellers we have priced
| Nex Gen Health Rx | $57.32/mo, Glutathione injection |
|---|---|
| Contour Health | $60/mo, NAD+ injection |
| Collective | $76/mo, Semaglutide injection |
| Avono Health | $79/mo, Semaglutide injection |
| Lean Meds | $79/mo, Semaglutide injection |
| RxPepsDirect | $80 per vial, Sermorelin injection |
| Enhanced | $89/mo, Semaglutide injection |
| Citizen Meds | $91/mo, NAD+ injection |
Where every figure comes from
- Current services and access claims
- Insurance-dependent brand offers and quarterly semaglutide headline
- Platform and independent clinical group terms
- Membership billing, cancellation and refund policy
- FDA warning letter 728293
- Clinical group and telehealth consent